Spotlight: Apr 2, 2026
Researchers discovered why cancer drugs called tyrosine kinase inhibitors don’t always work as expected: Some tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase is turned off. Combining therapies may offer a solution.